US2005002937A1PendingUtilityA1
Anti-IL-12 antibodies, compositions, methods and uses
Priority: Aug 7, 2000Filed: Aug 6, 2004Published: Jan 6, 2005
Est. expiryAug 7, 2020(expired)· nominal 20-yr term from priority
A61P 37/04A61P 9/00A61P 37/00A61P 37/08A61P 37/06A61P 43/00A61P 35/00A61P 25/20A61P 31/00A61P 25/00A61P 25/28A61P 29/00A61P 23/00A61P 21/02A61P 19/02A61P 17/06A61P 23/02A61P 1/00A61K 2039/505C07K 16/244C07K 2317/21A61K 39/3955C07K 2317/92A61K 45/06C07K 2317/76C07K 2317/565C07K 16/24
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to at least one novel anti-IL-12 antibodies, including isolated nucleic acids that encode at least one anti-IL-12 antibody, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Claims
exact text as granted — not AI-modified1 . An isolated human antibody, or an antigen-binding portion thereof, that binds to human IL-12, wherein said human antibody is a neutralizing antibody.
2 - 101 . (Canceled)Join the waitlist — get patent alerts
Track US2005002937A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.